Acute heart failure: diagnosis and management

dysfunction, once their condition has been stabilised – for example, when intravenous diuretics are no longer needed. • Ensure that the person's condition is stable for typically 48 hours after starting or restarting beta-blockers and before discharging from hospital. • Offer an angiotensin-converting enzyme inhibitor (or angiotensin receptor blocker if there are intolerable side effects) and an aldosterone antagonist during hospital admission to people with acute heart failure and reduced left ventricular ejection fraction. If the angiotensin-converting enzyme inhibitor (or angiotensin receptor blocker) is not tolerated an aldosterone antagonist should still be offered. Acute heart failure: diagnosis and management (CG187) Recommendations People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding. The following guidance is based on the best available evidence. The full guideline gives details of the methods and the evidence used to develop the guidance. 1.1 Organisation of care 1.1.1
